Increased urinary F2-isoprostanes levels in the patients with Alzheimer's disease

Brain Research Bulletin

Volumn 64, Issue 1, 2004, Pages 47-51

  Kim, Kyung Mee ^a,b   Jung, Byung Hwa ^a   Paeng, Ki Jung ^b   Kim, Inseong ^c   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Gongju Geriatric Hospital   (South Korea)

Author keywords

Alzheimer's disease; F2 isoprostanes; Gas chromatography mass spectrometry; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; URINE LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DINOPROST; F2-ISOPROSTANES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; PROSTAGLANDINS F;

EID: 3242690571     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2004.04.016     Document Type: Article

References (23)

1. Bai H., Konat G.W. Hydrogen peroxide mediates higher order chromatin degradation. Neurochem. Int. 42:2003;123-129
2. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779
3. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:2000;621S-629S
4. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 287:2002;3223-3229
5. Galasko D. Cerebrospinal fluid opens a window on Alzheimer disease. Arch. Neurol. 56:1999;655-656
6. Greco A., Minghetti L., Levi G. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem. Res. 25:2000;1357-1364
7. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1990;1-85
8. Hartman D. Free radical theory of aging: Alzheimer's disease pathogenesis. Age. 18:1995;97-119
9. Husdan H., Rapoport A. Estimation of creatinine by the Jaffe reaction. A comparison of three methods. Clin. Chem. 14:1968;222-238
10. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147
11. McIlroy S.P., Vahidassr M.D., Savage D.A., Patterson C.C., Lawson J.T., Passmore A.P. Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland. Am. J. Med. Genet. 88:1999;140-144
12. 2- isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Arch. Pathol. Lab. Med. 125:2001;510-512
13. 2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44:1998;410-413
14. 2- isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Ann. Neurol. 48:2000;950
15. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Wilson R.S., Scherr P.A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 287:2002;3230-3237
16. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9383-9387
17. 2α. J. Biol. Chem. 270:1995;9800-9808
18. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12:1998;1777-1783
19. Shastry B.S. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43:2003;1-7
20. Soriano F.X., Galbete J.L., Forloni G. Effect of β-amyloid on endothelial cells: lack of direct toxicity, enhancement of MTT-induced cell death and intracellular accumulation. Neurochem. Int. 43:2003;251-261
21. Tuppo E.E., Forman L.J., Spur B.W., Chan-Ting R.E., Chopra A., Cavalieri T.A. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. Brain Res. Bull. 54:2001;565-568
22. Wang L., Osborne P.G., Yu X., Shangguan D., Zhao R., Han H., Liu G. Hyperoxia caused by microdialysis perfusion decreased striatal monoamines: involvement of oxidative stress. Neurochem. Int. 42:2003;465-470
23. 2-isoprostanes. Clin. Chem. 47:2001;1306-1308